Graeme Bell
Overview
Graeme Bell received an average of $3M in total compensation, including $333K in salary, at Intellia Therapeutics between 2017 and 2018.
Source: SEC filings on April 16, 2019 and April 17, 2018.
Related executives
We found eight more executives who work or worked at Intellia Therapeutics.
James Basta
Intellia Therapeutics
General Counsel
John Leonard
Intellia Therapeutics
Chief Executive Officer
Laura Sepp-Lorenzino
Intellia Therapeutics
Chief Scientific Officer
David Lebwohl
Intellia Therapeutics
Chief Medical Officer
Glenn Goddard
Intellia Therapeutics
Chief Financial Officer
Andrew Schiermeier
Intellia Therapeutics
Chief Operating Officer
José Rivera
Intellia Therapeutics
General Counsel
Nessan Bermingham
Intellia Therapeutics